Cargando…
The Role of Glycoprotein IIb/IIIa Inhibitors- A Promise Not Kept?
For over one decade Glycoproteins IIb/IIIa inhibitors (GPI) have been administered to prevent coronary artery thrombosis. Initially these agents were used for acute coronary syndromes and subsequently as adjunctive pharmacotherapy for percutaneous coronary interventions (PCIs). Most benefit of GPI e...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Bentham Science Publishers Ltd.
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2779356/ https://www.ncbi.nlm.nih.gov/pubmed/19936282 http://dx.doi.org/10.2174/157340308784245793 |